New insulin lyumjev tested for safety in indian diabetes patients

NCT ID NCT06370715

Completed Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested the safety of Lyumjev, a rapid-acting insulin, in 150 adults with type 2 diabetes in India. Participants used Lyumjev along with their usual long-acting insulin for 26 weeks. The main goal was to see how many people had low blood sugar episodes. The study is already completed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Lyumjev (insulin lispro-aabc) and insulin glargine
What this could lead to: If successful, this study could confirm that Lyumjev is a safe option for managing blood sugar in adults with type 2 diabetes in India.
What could go wrong: This is a single-arm, open-label study with no comparison group, so results may not be definitive. Hypoglycemia (low blood sugar) is a known risk with insulin therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Brij Medical Center Pvt. Ltd.

Kanpur, Uttar Pradesh, 208020, India
Center for Diabetes and Endocrine Care

Bengaluru, Karnataka, 560043, India
Chellaram Diabetes Institute

Pune, Maharashtra, 411021, India
Diabetes Research Centre

Royapuram, Chennai India, 600013, India
King George Hospital, Visakhapatnam

Visakhapatnam, Andhra Pradesh, 530002, India
Kovai Diabetes Speciality Center and Hospital

Coimbatore, Tamil Nadu, 641009, India
Medical College & Hospital, Kolkata

Kolkata, West Bengal, 700073, India
Osmania Medical College & Hospital

Hyderabad, Andhra Pradesh, 500012, India
Rajasthan University of Health Sciences

Jaipur, Rajasthan, 302033, India
S. P. Medical College & A G Hospital

Bikaner, Rajasthan, 334003, India
Sahyadri Super Speciality Hospital

Pune, Maharashtra, 411004, India
Vijyaratna Dibetes Diagnosis Treatment Centre

Ahmedabad, Gujarat, 380007, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.